Evidence map›Paper›PMID 38930950›Full record

ArticleMolecules (Basel, Switzerland)2024

Structural, Biophysical, and Computational Studies of a Murine Light Chain Dimer.

Ricardo H Arriaza, A Brenda Kapingidza, Coleman Dolamore, Kriti Khatri, Andrea O'Malley, Jill Glesner, Sabina Wuenschmann, Noah P Hyduke, William Easley, Charline Chhiv and 2 more

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ricardo H ArriazaDepartment of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI 48864, USA.
A Brenda KapingidzaDepartment of Chemistry and Biochemistry, University of South Carolina, Columbia, SC 29208, USA.
Coleman DolamoreDepartment of Chemistry and Biochemistry, University of South Carolina, Columbia, SC 29208, USA.
Kriti KhatriDepartment of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI 48864, USA.ORCID 0000-0002-4757-2677
Andrea O'MalleyDepartment of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI 48864, USA.
Jill GlesnerInBio, Charlottesville, VA 22903, USA.ORCID 0009-0004-0258-4529
Sabina WuenschmannInBio, Charlottesville, VA 22903, USA.
Noah P HydukeDepartment of Chemistry and Biochemistry, University of South Carolina, Columbia, SC 29208, USA.
William EasleyDepartment of Chemistry and Biochemistry, University of South Carolina, Columbia, SC 29208, USA.
Charline ChhivDepartment of Chemistry and Biochemistry, University of South Carolina, Columbia, SC 29208, USA.
Anna PomésInBio, Charlottesville, VA 22903, USA.ORCID 0000-0002-8729-1829
Maksymilian ChruszczDepartment of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI 48864, USA.ORCID 0000-0001-7521-5485

Funding

Antigenic determinants of asthma-associated allergens for design of immunotherapy.R01AI077653 · NIAID · INDOOR BIOTECHNOLOGIES · PI MARTIN D. CHAPMAN, Maksymilian Chruszcz · 2009 to 2026
$9.5M
National Institute of Allergy and Infectious Diseases of the National Institutes of Health R01AI077653-13NIAID NIH HHS R01 AI077653
6 · The paper itself

Abstract

Antibodies are widely used in medicinal and scientific research due to their ability to bind to a specific antigen. Most often, antibodies are composed of heavy and light chain domains. Under physiological conditions, light chains are produced in excess, as compared to the heavy chain. It is now known that light chains are not silent partners of the heavy chain and can modulate the immune response independently. In this work, the first crystal structure of a light chain dimer originating from mice is described. It represents the light chain dimer of 6A8, a monoclonal antibody specific to the allergen Der f 1. Building on the unexpected occurrence of this kind of dimer, we have demonstrated that this light chain is stable in solution alone. Moreover, enzyme-linked immunosorbent assays (ELISA) have revealed that, when the light chain is not partnered to its corresponding heavy chain, it interacts non-specifically with a wide range of proteins. Computational studies were used to provide insight on the role of the 6A8 heavy chain domain in the specific binding to Der f 1. Overall, this work demonstrates and supports the ongoing notion that light chains can function by themselves and are not silent partners of heavy chains.

Indexed as

Immunoglobulin Light ChainsProtein MultimerizationAnimalsAntibodies, MonoclonalCrystallography, X-RayImmunoglobulin Heavy ChainsMiceModels, MolecularProtein BindingProtein ConformationAntibodies, MonoclonalImmunoglobulin Heavy ChainsImmunoglobulin Light ChainsallergenantibodycrystallographyDer f 1dimerization

Identifiers

PMID38930950
PMCPMC11206851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.